Abbott recieves EU nod for balloon dilation catheter system

Kaitlyn Dmyterko | | Health Imaging | Diagnostic Imaging
Abbott Laboratories has received European regulatory approval for its Trek and Mini-Trek coronary dilation balloon catheters, which are indicated for the treatment of coronary artery disease.

The Trek systems received CE mark in May 2010 and are used during angioplasty procedures to aid in the opening of patients’ narrowed coronary arteries.

According to the Abbott Park, Ill.-based company, the Trek RX system is available for use in Japan and the Trek RX and Trek OTW are now available for use in the U.S. The devices are available in two designs: the Mini-Trek (U.S. in 1.5 to 2 mm sizes and Japan, 1.2 to 2 mm) and the Trek system available in over 70 sizes and diameters (1.2mm to 5 mm) and lengths (6 mm to 30 mm).

With the latest approval, the devices are available for use in all worldwide markets.

Kaitlyn Dmyterko

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.